Demand Analysis of Cardiac and Diabetic Medicines in the Indian Market

There is a substantial transformation occurring in the Indian Pharmaceutical market which has two therapy segments as a stronger growth engine-Cardiac and anti-diabetic medicines. Driven by rapid changes in disease burden, urbanization and lifestyle, demand for these drugs will never fall flat.

The Scale of the Problem

The figures are astonishing, cardiovascular diseases cause 28% of all deaths in India as reported by WHO whereas more than 80 million Indians are currently suffering from diabetes and it is estimated to be more than 98 million in 2025. INDIAB report by the Indian Council of Medical Research claims there are 101 million Indians suffering from diabetes and the risk factors are urbanisation, age, obesity, poor diet and genetic factor. 

The dual epidemics lead to persistent growing demand in both the therapy segments. The TribuneInternational Journal of Pharmaceutical Sciences

Market Size and Growth Trajectory

The figures indicate robust commercial demand. India's diabetes care drugs market was valued at USD 4.6 billion in 2024 and is expected to reach USD 13.5 billion by 2032 at a CAGR of 14.4%. According to recent market reports, the Cardiac market registered significant growth of 13.2% in value terms in August 2025 of Indian Pharmaceutical Market whereas anti-diabetic drugs grew by 9.4% in the same period.

India Pharmaceutical Market is expected to reach USD 78 billion by 2025 at a CAGR of 10-12%. Verified Market Research + 2

Key Demand Drivers

Several fundamental factors are fueling the demand: the rise in incidence of type 2 diabetes and hypertension at younger age groups has escalated with fast paced urbanisation and increasing sedentary lifestyles. Accessibility to better healthcare, support of various government initiatives and availability of better drug formulation are considered as key drivers for the Indian diabetes care drugs market.

 On the contrary, awareness, accessibility of improved diagnosis and reach of specialists to Tier 2 and 3 cities are crucial drivers for the Cardiac market. Verified Market Research

Distribution and Access

Hospital pharmacies registered the major market share of 66.78% value share in 2024, whereas online pharmacies are at a faster CAGR growth rate of 4.56% for 2025-2030. Access to the critical cardiac and diabetic drugs is also becoming wider due to Franchise based pharmaceutical distribution models that is bridging the gaps of access in semi urban and rural areas of India. Mordor Intelligence

The Generic Opportunity

India is known for its strength in generics and is making these drugs accessible by making them affordable. Indian market sees 147 generic brands entering the market after patent cliff of empagliflozin in March 2025 and hence bringing relief to price-sensitive patients.

Conclusion

Growing demand for cardiac and diabetic medicine in India means a lucrative, long-term business prospect-and partnering with the right company ensures your success. Scott Morrison is a ISO certified cardiac diabetic PCD pharma franchise company and they are ideal for right now. We have:

  • WHO-GMP certified & DCGI-approved product portfolio
  • Monopoly based PCD franchise across PAN India
  • 20-30% profit margins to its franchise partners
  • More than 36 cardiac & more than 49 diabetic formulation options
  • 24-48 hours delivery with full promotion support

For better business prospects, connect with Scott Morrison for cardiac diabetic business growth.

Comments

Post a Comment

Popular posts from this blog

Top Cardiac Diabetic PCD Franchise Company in India

  Best Cardiac Diabetic PCD Company - Scott Morrison provides good quality medicines for people with diabetes and heart problems. You can rely on us for your medical needs. We promise to offer high-quality medicine and services to doctors around the world as a leading company in heart and diabetes care. We are very happy about our Cardiac Diabetic PCD Franchise . It helps us to grow and make the lives of patients better. As a company that sells medicine for heart and diabetes problems, we make sure our franchise partners get lots of help, like advertising materials, training, and advice, to help them start a successful business. We believe in building strong relationships and helping our franchise partners succeed together. Advantages of Collaborating with Cardiac Diabetic PCD Franchise Company Working with a company that sells medicine for heart and diabetes problems has a lot of benefits for people who want to start a career in the medicine industry. Provide care for patients wit...
Read more

Step-by-Step Guide to Start an Antispasmodic PCD Pharma Franchise in India

Image
 The pharmaceutical sector in India is expanding rapidly, offering numerous opportunities for entrepreneurs and distributors. One of the most promising segments is the antispasmodic category, driven by increasing demand for digestive and pain-relief medications. If you are planning to enter this field, starting an Antispasmodic PCD Pharma Franchise in India can be a profitable and scalable business model. With low investment, monopoly rights, and strong product demand, it has become a preferred choice for many aspiring pharma professionals. Why Choose an Antispasmodic Pharma Franchise? Before diving into the steps, it’s important to understand why this segment is worth investing in: Rising cases of gastrointestinal disorders and abdominal pain High demand for antispasmodic medicines in urban and rural areas Low competition compared to other pharma segments Opportunity to build a long-term distribution network Step-by-Step Guide to Start Your Franchise 1. Conduct Mark...
Read more

Future Scope of the Diabetic PCD Franchise Industry in India

India is witnessing a significant rise in lifestyle-related diseases, with diabetes becoming one of the most common health concerns across urban and rural populations. The growing prevalence of diabetes has increased the demand for specialized medicines and healthcare solutions. As a result, the pharmaceutical sector is experiencing tremendous growth, particularly in diabetes care products. Entrepreneurs and distributors are increasingly partnering with a Diabetic PCD Franchise Company in India to capitalize on this expanding market. With continuous advancements in healthcare and increasing awareness about diabetes management, the future of the diabetic pharma franchise industry appears highly promising. The diabetic franchise business offers a profitable opportunity for individuals who want to establish themselves in the pharmaceutical sector without investing in large manufacturing facilities. The combination of rising healthcare needs, supportive government initiatives, and growing...
Read more